NANETS is pleased to announce the 2021 Research Grant Recipients

BTSI

 

J. Barton Rose, MD
University of Alabama
BTSI

NANETS congratulations J. Barton Rose,III, MD of the University of Alabama, as the 2021 recipient of NANETS’ Basic/Translational Science Investigator Award (BTSI). Dr. Rose was awarded this scholarship for his proposal: Molecular influences of racial disparities in pancreatic neuroendocrine tumors. Dr. Rose is an Assistant Professor of Surgical Oncology at the University of Alabama at Birmingham.He has been involved in research for nearly 20 years, with a focus on NET research in the past four years.

Dr. Rose noted that, as the only comprehensive cancer center located in the Deep South, he treats a diverse population, and nearly 30 percent of patients are Black.
“We noticedt differences in the clinical presentation between our Black and White patients and felt there was a huge need to pursue this line of investigation, especially when our early studies have suggested there are some genetic differences between these patient populations.”

He noted the importance of identifying the molecular drivers that are different for these groups, and the potential to discover treatments that are better and can potentially allow physicians to personalize treatment.

The purpose of the BTSI Award is to encourage scientists at the end of their fellowship who have secured a faculty appointment or scientists beginning their faculty appointment to pursue research focused on neuroendocrine tumors. This grant has been supported by the Neuroendocrine Tumor Research Foundation (NETRF) since 2016.

"NANETS is delighted to have the opportunity to support Dr. Rose, who joins a long line of exceptionally promising early-career investigators to receive these grants. In keeping with the mission of these grants to encourage the development of outstanding clinical and laboratory-based investigators in the critical first few years of their careers, many prior grantees have gone on to make substantial contributions to the NET field and NANETS itself, including many of our current board members and committee chairs. We look forward to Dr. Rose's continued contributions and enthusiasm over the coming years," commented Daniel Halperin, MD, Chair, Scientific Review & Research Committee.

 

 

NCIS

Brendan Finnerty, MD
New York Presbyterian Hospital - Weill Cornell Medicine
NCIS

NANETS congratulates Brendan Finnerty, MD of Weill Cornell Medicine as the NANETS 2020 Clinical Investigator Scholarship (NCIS) award recipient. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors.  

Dr. Finnerty received the scholarship for his proposal, "Developing a Predictive Molecular Model for Cytologic Detection of Aggressive Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study." Dr. Finnerty will be mentored by Dr. Thomas Fahey, III, Chief of Endocrine and Minimally Invasive Surgery and Professor of Surgery at New York Presbyterian Hospital - Weill Cornell Medicine.

The NCIS grant is a two-year, $100,000 award funded through the generous support of Ipsen Biopharmaceuticals, who has been a funding partner of NANETS since the research grant program’s inception in 2009. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors. The NANETS Scientific Review & Research Committee establishes the award criteria, reviews process, and independently selects the recipient.

Theranostics

Heloisa Soares, MD, PhD
University of Utah, Division of Oncology
Theranostics

NANETS congratulates Heloisa Soares, MD, PhD of the University of Utah as the NANETS 2020 Theranostics Investigator Scholarship (NTIG) award recipient. The NTIG is intended to push forward the boundaries of molecularly targeted radionuclide therapy and diagnostics for patients with neuroendocrine tumors.

Dr. Soares received the scholarship for her proposal, “The Role of HDAC Inhibitors in Combination to PRRT in NET Xenografts.” Dr. Soares will be mentored by Kathryn Morton, MD, Professor of Radiology at the University of Utah.

NTIG is made possible by the support of Advanced Accelerator Applications (AAA), a long-time supporter of NANETS’ educational events and research. NTIG is a two-year, $100,000 award.

NANETS is pleased to announce the 2020 Research Grant Recipients

BTSI

NCIS

Brendan Finnerty, MD
New York Presbyterian Hospital - Weill Cornell Medicine
NCIS

NANETS congratulates Brendan Finnerty, MD of Weill Cornell Medicine as the NANETS 2020 Clinical Investigator Scholarship (NCIS) award recipient. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors.  

Dr. Finnerty received the scholarship for his proposal, "Developing a Predictive Molecular Model for Cytologic Detection of Aggressive Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study." Dr. Finnerty will be mentored by Dr. Thomas Fahey, III, Chief of Endocrine and Minimally Invasive Surgery and Professor of Surgery at New York Presbyterian Hospital - Weill Cornell Medicine.

The NCIS grant is a two-year, $100,000 award funded through the generous support of Ipsen Biopharmaceuticals, who has been a funding partner of NANETS since the research grant program’s inception in 2009. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors. The NANETS Scientific Review & Research Committee establishes the award criteria, reviews process, and independently selects the recipient.

Theranostics

Heloisa Soares, MD, PhD
University of Utah, Division of Oncology
Theranostics

NANETS congratulates Heloisa Soares, MD, PhD of the University of Utah as the NANETS 2020 Theranostics Investigator Scholarship (NTIG) award recipient. The NTIG is intended to push forward the boundaries of molecularly targeted radionuclide therapy and diagnostics for patients with neuroendocrine tumors.

Dr. Soares received the scholarship for her proposal, “The Role of HDAC Inhibitors in Combination to PRRT in NET Xenografts.” Dr. Soares will be mentored by Kathryn Morton, MD, Professor of Radiology at the University of Utah.

NTIG is made possible by the support of Advanced Accelerator Applications (AAA), a long-time supporter of NANETS’ educational events and research. NTIG is a two-year, $100,000 award.

201620